131I-MIBG

A drug containing a form of radioactive iodine called I 131 that is used to treat malignant pheochromocytoma and paraganglioma. It is used in patients who need treatment with systemic anticancer therapy and whose tumor cells take up radioactive iobenguane and are detected by a scanner. 131I-MIBG is used to treat pheochromocytoma and paraganglioma that cannot be removed by surgery, are locally advanced, or have spread to other parts of the body. It is also being studied in the treatment of other types of cancer. 131I-MIBG builds up in tumor cells and gives off radiation that may kill the tumor cells. It is a type of radioconjugate. Also called Azedra, iobenguane I 131, and iodine I 131-metaiodobenzylguanidine.

• Dailymed label info on 131I-MIBG
• FDA 131I-MIBG

131I-MIBG Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski